• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·6637.TWO
Share

Medical Imaging Corporation Stocks

NT$ 63.6Last Updated 23.07.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 51.94M

NT$ 63.6
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Medical Imaging Corporation, actively operating in China, specializes in providing leasing and management solutions for medical imaging technology. Its comprehensive product portfolio includes sophisticated diagnostic devices such as ultrasound equipment and bone density detectors. Beyond imaging, the company also supplies specialized medical infrastructure like emergency rooms and intensive isolation wards, along with advanced intelligent lead plates for radiation protection. Additionally, it engages in the wholesale distribution of a wide range of medical equipment and pharmaceuticals. The company was founded in 1978 and maintains its headquarters in Taipei, Taiwan.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, overpriced on

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 6637.TWO is 163 and suggests 155% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.07.2026 16:06

The "Golden Age" of Euro-Denominated Stablecoins: How Investors Can Profit from Them

23.07.2026 15:45

Morning in New York: Corporate Earnings in the Spotlight

23.07.2026 15:35

"Bulls Can Confidently Aim for $100 a Barrel": Brent Jumps Above $98

23.07.2026 14:57

BofA has placed its bets on recent market leaders following the sell-off. It is expecting a reversal.

23.07.2026 14:43

The yield on 10-year German government bonds reached a 15-year high

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026